Clinical Trials in Houston

Showing 1201-1220 of 8,625 trials

RECRUITINGPhase 1< 1 mile

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

NCT06414889

To evaluate the safety and feasibility of collecting hematopoietic stem cells (HSC) in participants with RUNX1-FPD.

RUNX1 Familial Platelet Disorder

M.D. Anderson Cancer Center4 participantsStarted May 2024

Houston, Texas, United States

RECRUITINGNA< 1 mile

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

NCT06736600

A behavioral trial aimed at helping patients identify what matters most to them and is part of a larger effort to pivot from disease-oriented care to whole-person care.

Peripheral Neuropathy Due to Chemotherapy

M.D. Anderson Cancer Center45 participantsStarted Apr 2025

Houston, Texas, United States

RECRUITINGPhase 1/2< 1 mile

A Study of YL242 in Subjects With Advanced Solid Tumors

NCT07197827

This is a multicenter, open-label study to evaluate the safety and tolerability of YL242 monotherapy and combination in participants with advanced solid malignant tumors.

Advanced Solid Tumor

MediLink Therapeutics (Suzhou) Co., Ltd.424 participantsStarted Sep 2025

New Haven, Connecticut, United States • Sarasota, Florida, United States • Boston, Massachusetts, United States +12 more locations

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

A Study of YL242 in Subjects With Advanced Solid Tumors

Find Trials by Condition in Houston

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Ribociclib and Letrozole Treatment in Ovarian Cancer

SP Thoracic IDE Study

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Observational Study Protocol: LIVER-R

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Clinical and Molecular Studies in Families With Inherited Eye Disease